Mecobalamin
Hand-foot Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Hand-foot Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Swiss Cancer Institute | Phase 3 | BB |
Dfn-15 Affiliated Hospital of Qinghai University | Phase 3 | B |
ADVICOR COMPONENT NIACIN First People's Hospital of Hangzhou | Phase 2 | CCC |
Tazarotene Dana-Farber Cancer Institute | Phase 2 | CCC |
Nicotine University of California, San Francisco | Phase 2 | CCC |
View all 11 →
Same molecule, other indications
Mecobalamin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →